We investigated, in isolated bile duct units (IBDU) and cholangiocytes isolated from normal rat liver, the occurrence of acetylcholine (ACh) receptors, and the role and mechanisms of ACh in the regulation of the Cl Ϫ /HCO 3 Ϫ exchanger activity. The Cl Ϫ /HCO 3 Ϫ exchanger activity was evaluated measuring changes in intracellular pH induced by acute Cl Ϫ removal/readmission. M3 subtype ACh receptors were detected in IBDU and isolated cholangiocytes by immunofluorescence, immunoelectron microscopy, and reverse transcriptase PCR. M1 subtype ACh receptor mRNA was not detected by reverse transcriptase PCR and M2 subtype was negative by immunofluorescence. ACh (10 M) showed no effect on the basal activity of the Cl Ϫ /HCO 3 Ϫ exchanger. When IBDU were exposed to ACh plus secretin, ACh significantly ( P Ͻ 0.03) increased the maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of recovery after Cl 
Introduction
Cholangiocytes lining the intrahepatic biliary tree play an important role in modifying the composition of canalicular bile through secretory or reabsorptive processes (1) (2) (3) . Bicarbonate excretion in bile is a major function of the biliary epithelium and is predominantly driven by an apical located Cl Ϫ / HCO 3 Ϫ exchanger. Fluid and bicarbonate secretion from bile ducts is under hormonal regulation (1) (2) (3) . Secretin (4), bombesin (5) , and vasoactive intestinal peptide (6) induce ductal choleresis by enhancing, in cholangiocytes, bicarbonate excretion through the stimulation of the Cl Ϫ /HCO 3 Ϫ exchanger. In contrast, somatostatin (7) and gastrin (8) inhibit ductal fluid secretion. The cholinergic system plays a fundamental role in controlling gastrointestinal physiology through the regulation of vascular, metabolic, and secretory events, as well as motility (9, 10) . However, currently available data on the role of the cholinergic system in the regulation of bile secretion or ductal fluid secretion are scanty. In bile-fistula dogs with interrupted enterohepatic circulation, distal stimulation of the vagus nerve increases bile flow and bicarbonate biliary excretion, while vagotomy decreases basal bile flow and bicarbonate output (11, 12) . In anaesthetized sheep (13) , vagal electrical stimulation enhances bicarbonate biliary output without significant changes in bile flow. Insulin stimulation of bile flow is thought to be mediated by cholinergic mechanisms being inhibited by atropine (14) . At the cellular level, the acetylcholine agonist, carbachol, induces bicarbonate rich fluid secretion in pancreatic tissue (15) , salivary glands (16) , and eccrine sweat glands (17) , and uses Ca 2 ϩ as its intracellular messenger. As far as liver cells are concerned, while showing no effect in isolated hepatocytes, acetylcholine elicits Ca 2 ϩ increase and oscillation in isolated bile duct units (IBDU), 1 due to both influx of extracellular Ca 2 ϩ and the mobilization of thapsigargin-sensitive Ca 2 ϩ stores (18). This indicates the presense of muscarinic receptors in the biliary system but not in hepatocytes.
The aim of this study was to investigate the occurrence of acetylcholine (ACh) receptors as well as the role and mechanisms of ACh in the regulation of Cl Ϫ /HCO 3 Ϫ exchanger activity in IBDU and in pure preparations of cholangiocytes isolated from rat liver.
Methods

Materials
ACh, secretin, carbachol, collagenase A, BSA (essential fatty acid free), EDTA, penicillin/streptomycin, heparin, Hepes, D( ϩ )glucose, insulin, soybean trypsin inhibitor (type I-s), DMSO, deoxyribonuclease (DN-25), nigericin, Na 
Isolation of bile duct units
Male Sprague-Dawley rats (CD strain; Charles River Italia, Calco, Italy) weighing 200-270 g, were housed in temperature and light controlled rooms, maintained on a GLP diet in pellets (Nossan, Correzzana, Italy), and were given water ad libitum. Animals received humane care and the study protocol was in compliance with our institution's ethical guidelines. IBDU were prepared as described previously (19, 20) . In brief, the animals were anesthetized intraperitoneally with pentobarbital (50 mg/kg), the portal vein was cannulated by a 16 gauge cannula and the liver perfused in situ for 10 min with Ca 2 ϩ , Mg 2 ϩ -free Hanks' medium/0.019% EDTA, and then for 10-15 min with Ca 2 ϩ and Mg 2 ϩ containing Hanks' buffer supplemented with 0.05% collagenase A. The portal tissue residue was separated mechanically from parenchymal tissue and then finely minced, enzymatically digested in a solution containing collagenase (0.066%), pronase (0.033%), and DNase (3%), and sequentially filtered through 100-and 30-m mesh Nitex Swiss nylon monofilament screens (Tetko Co., Elmsford, NY). Fragments remaining on the filters were further digested in a solution containing pronase (0.033%) and DNase (3%). Fragments were then filtered again through 100-and 30-m mesh and those remaining on the 30-m filter were collected in 4-10 ml ␣ -MEM medium supplemented with 0.1-M insulin, 3% FCS, 2-mM L -glutamine, gentamicin (550 g/ml), and penicillin/streptomycin (100,000 U, 100 mg/liter). Bile duct fragments were used for indirect immunofluorescence, immunoelectron microscopy, and for functional study as described below. For indirect immunofluorescence, part of the material was embedded in Tissue Tek, snap-frozen in isopentane precooled in liquid nitrogen and stored at Ϫ 70 Њ C. 4-m-thick cryostat sections were cut, placed on gelatin-coated slides, and fixed in absolute acetone for 10 min. For immunoelectron microscopy, small fragments of IBDU were fixed in periodate-lysine-paraformaldehyde for 1 h at 4 Њ C, rinsed in PBS, and exposed to the antibody as shown below. The functional study fragments were plated on small coverslips, (4 ϫ 2 mm), layered in 12-mm diameter tissue culture plastic wells (Corning Glass Works, Corning, NY), covered with a thin layer of Matrigel and incubated at 37 Њ C in a 95% O 2 /5% CO 2 -equilibrated incubator. The medium was changed after 24 h and the experiments performed between 24-48 h after plating. Viability (trypan blue exclusion) was evaluated in plated IBDU at the beginning and end of the functional study and in the presence of both agonists and antagonists.
Light microscopy
Indirect immunofluorescence. The sections were rinsed in PBS and incubated for 1 h at room temperature in normal sera to suppress nonspecific antibody binding. Thereafter, the sections were incubated overnight at 4 Њ C with mouse anti-mAChR mAb M35 monoclonal antibody (50 g/ml; Chemunex, Maisons-Alfort, France) ( n ϭ 25) in PBS. In paired experiments ( n ϭ 20), the sections were preincubated with 40 nM of 4-DAMP for 30 min at room temperature and then incubated with M35 mAb as described previously. The M35 antibody was raised in mice against muscarinic receptor protein purified from bovine forebrain homogenates and was shown to recognize the M2 and M3 subtypes (21) (22) (23) . PBS was only used in negative controls. Binding of mAb M35 was visualized by exposure to goat anti-mouse IgG conjugated with FITC (Sigma Chemical Co.; F-5897). In different experiments ( n ϭ 15), the sections were incubated overnight at 4 Њ C with M2 muscarinic ACh receptor mAb (2 g/ml; Chemicon International Inc., Temecula, CA) in PBS. The M2 muscarinic ACh receptor mAb is specific for the M2 receptor and shows no cross-reactivity with the other subtypes (M1, M2, or M4). PBS only was used in negative controls. The fluorescent signal was analyzed by a quantitative image analysis system (Olympus Cue-3 versus Image analyzer) connected to an Olympus inverted epifluorescence microscope and observed through a ϫ 60 Nomarski optic. An excitation wavelength of 440 nm was used. Emitted light (510-nm dichroic mirror, 510-560-nm band pass filter) was transmitted through an image intensifier in a CCD camera (Hamamatsu model C-5310, type 11; Hamamatsu Phototonics, Hamamatsu City, Japan). Finally, fluorescence emission intensity was quantified using a computerized system. Briefly, in every single cell of bile ductules incubated with M35 antibody, the fluorescent signal was measured both at the basolateral and at the apical area. Values were corrected for the background fluorescence obtained from a region with no cells and secondly for the background measured in the cellular space. Such background fluorescence was evaluated by means of a thresholding procedure (24) . These parameters were calculated in bile ducts of different diameters ( Ͻ 50 m and Ͼ 50 m).
Immunoperoxidase
After rinsing in PBS, the fragments of IBDU were preincubated in 0.1-M phosphate buffer, pH 7.4, containing 20% normal swine serum for 1 h at room temperature. Subsequently, the sections were rinsed in PBS (3 ϫ 10 min) and then incubated with the primary mAb M35 for 2 h at room temperature. After incubation, sections were washed in PBS (3 ϫ 10 min). A rabbit anti-mouse antibody (1:50; DAKO-PATTS, Copenhagen, Denmark) was used as the secondary antibody for 30 min at room temperature. Finally, the sections were incubated with a peroxidase-conjugated swine antibody (1:50; DAKOPATTS), as tertiary antibody, for 30 min at room temperature. Sections were rinsed again with PBS (3 ϫ 10 min) and the reaction product was visualized with diaminobenzidine (DAB) for light and electron microscopy.
1. Abbreviations used in this paper: ACh, acetylcholine; ␤ i , intrinsic buffering power; BAPTA/AM, 1,2-bis (a-Aminophenoxy)ethane-N,N,N Ј ,N Ј -tetraacetic acid acetoxymethylester; BCECF-AM, 2,7,bis-(carboxyethyl)-5-(6)-carboxy-fluorescein-acetomethylester; 4-DAMP, 4-diphenyl-acetoxy-N -(2-chloroethyl)-piperidine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IBDU, isolated bile duct units; PKC, protein kinase C; RT-PCR, reverse transcriptase PCR.
For light microscopy, the developed sections were mounted on glass slides with clearium. Controls were performed by omission of the primary antibody. Microphotographs were taken using an Olympus Vanox photomicroscope equipped with an automatic image analyzer.
Electron microscopy
For electron microscopy, IBDU were processed as described above for light microscope up to the exposure to DAB. The samples were then fixed with 1% osmium tetroxide in 0.1-M phosphate buffer, pH 7.4, followed by dehydration and embedding in Epon/Araldite. Electron microscopy was performed on 60-nm ultrathin sections, with or without staining with lead citrate. The results were evaluated on fragments showing intact epithelium. This meant the presence of a continuous cellular wall surrounding the lumen of bile ducts, intact junctional complexes, no evidence of blebs on the plasma membrane, the identification of basement membrane components along the basolateral aspect of the cell, and intact microvilli on the luminal side.
Solutions
The composition of solutions used in the study have been described previously in detail (4, 19, 25, 26) . Secretin and ACh were made up as a concentrated solution in the appropriate perifusion buffer containing 1% (wt/vol) BSA. These were infused (1:50 vol/vol dilution) into the perifusion fluid, at a rate calculated to produce the required final concentration. Staurosporine, Cyclosporin A, and FK-506 were dissolved in DMSO (stock solution) and then diluted (1:10,000, vol/vol) to the required final concentration.
Intracellular pH (pH i ) determination
pH i was measured using a microfluorimetric single-cell method (SPEX-AR-CM-micro system; Spex Industries, Edison, NJ) and BCECF-AM as a fluorescent pH i indicator (4, 19, 25, 26) . IBDU on glass coverslips were loaded with BCECF-AM (12 M) for 40 min, washed for 10 min in a BCECF-free medium and transferred into a thermostated perfusion chamber placed on the stage of a Nikon Diaphot inverted microscope. The perfusion media were kept at 37 Њ C and gassed both by direct bubbling and an artificial lung. The microscope was connected with a rotating chopper mirror, which rapidly alternated the light generated by a 150 W xenon lamp between two excitation beams (490 and 440 nm). Light was attenuated to 0.1% by heat reflectors and neutral density filters (Omega Optics, Eugene, Oregon). The emitted light was read at 530 nm, integrated by the computer with 500 ms acquisitions every 1500 ms and displayed in real time. All measurements for each excitation wavelength were corrected for background fluorescence obtained from dye-free IBDU. Fluorescence intensity exceeded background autofluorescence at least 45-fold. The 490/440 Fi ratio data were converted to pH i values by using the nigericin (12 M) calibration curve technique (4, 19) . Over the pH range, 6.4-7.7, fluorescence varied in a linear fashion with pH out .
Total and intrinsic intracellular buffering power
The intrinsic buffering power ( ␤ i ) was determined at different pH i as described (4, 19, 25, 26) , by exposing the cells to 30-mM NH 4 Cl in Hepes, Na ϩ -free buffered solutions, and then decreasing the NH 4 Cl concentration by 5 or 10 mM for each step to 0 mM (n ϭ 9) from three IBDU preparations. The ␤ i was then calculated from the midpoint change in pH i at each step. ␤ i values were then plotted versus pH i using a best fit program (Enzfitter). As in other studies (8, 
Purification and phenotypic characterization of cholangiocytes from rat liver
After standard collagenase perfusion, a mixed nonparenchymal cell fraction ‫ف(‬ 50% pure by ␥-glutamyltranspeptidase) was isolated from portal tract residue as described previously (27) (28) (29) (30) (31) . Briefly, after a series of enzymatic digestions, virtually pure preparations of cholangiocytes were purified by immunoaffinity separation (27-31) using an antibody raised against an antigen expressed by all intrahepatic cholangiocytes (27) . Cell number and viability was assessed by standard trypan blue exclusion. Purity was assessed by histochemistry for ␥-glutamyltranspeptidase (32), a specific marker of cholangiocytes in rat liver (3, 27, 33) . The degree of contamination of cholangiocyte preparations was determined by positive identification for hepatocytes, endothelial, and mesenchymal cells as described previously (34) .
In vitro molecular analysis
The genetic expression of selected messages, i.e., M3 muscarinic ACh receptor and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the housekeeping gene (30, 31) , was measured by reverse transcriptase PCR (RT-PCR) using 5 ng of Poly A ϩ mRNA extracted from pure preparations of cholangiocytes by a commercially available kit (Invitrogen Corp.) according to the instructions supplied by the vendor. For the molecular analysis of M3 muscarinic ACh receptor standard RT-PCR conditions were used: 35 step cycles, 30 s at 94ЊC, 30 s at 55ЊC, and 45 s at 72ЊC. Specific oligonucleotide primers for the M3 muscarinic receptor gene (sense 5Ј-GAAGGAGAGGCATAC-CGCTAAAC-3Ј and antisense 5Ј-AGAACCAAGAGTCAAATC-CACGCTATAG-3Ј, expected fragment length 375 bp) were based on the rat M3 muscarinic ACh receptor sequence (35, 36) . For the molecular analysis of the M3 muscarinic ACh receptor genes, we used brain and yeast transfer RNA as positive and negative controls, respectively.
For the molecular analysis of the M1 muscarinic ACh receptor, specific oligonucleotide primers were designed from the coding region of the M1 rat muscarinic receptor (35) . The 5Ј sequence of the primers started at base pair 997 (5Ј-GGAGTCCCTCACATCCTC-CGA-3Ј) and the 3Ј sequence started at base pair 1471 (5Ј-CGC-CAGCGCCTCTTGTCCCAG-3Ј) with an expected fragment length of 474 bp. For the molecular analysis of the M1 muscarinic ACh receptor in pure preparations of cholangiocytes, we used the same RT-PCR conditions as Elsing et al. (37) : 30 cycles of denaturation at 95ЊC for 1 min annealing at 65ЊC for 1 min, and extension at 72ЊC for 1 min. Rat brain and yeast transfer RNA were used as positive and negative controls, respectively.
Specific primers for the GAPDH gene (sense 5Ј-GTGACT-TCAACAGCAACTCCCATTC-3Ј and antisense 5Ј-GTTATGGG-GTCTGGGATGGAATTGTG-3Ј, expected fragment length 294 bp) were based on the rat GAPDH sequence (38) . Rat kidney and yeast transfer RNA were the positive and negative controls for the GAPDH gene, respectively.
Intracellular cAMP levels
Basal-and agonist-induced intracellular cAMP levels in pure preparations of isolated cholangiocytes were measured at 22ЊC, as described previously by us (7, 29, 31) and others (39) . After isolation, cholangiocytes were incubated for 2 h at 37ЊC to restore secretin receptors damaged by treatment with proteolytic enzymes (39) and stimulated for 5 min at 22ЊC in the presence of 0.2% BSA with (a) secretin (50 nM); (b) ACh (10 M); (c) secretin (50 nM) plus ACh (10 M); (d) carbachol (100 M); (e) secretin 50 nM plus carbachol (100 M); or (f) 0.2% BSA. In a separate set of experiments, aliquots of the same cholangiocyte preparations were treated with 100-nM cyclosporin A or FK-506, two inhibitors of calcineurin (40, 41) , for 60 min at 37ЊC before being exposed to secretin (50 nM) or secretin (50 nM) plus ACh (10 M) for 5 min at 22ЊC. After extraction with ethanol, cAMP levels were determined by a commercially available kit (Amersham Corp.) according to the vendor's instructions. Intracellular cAMP levels were expressed as femtomol per 10 5 cells.
Statistical analysis
Data are presented as arithmetic meansϮSEM unless otherwise indicated. Statistical analysis was conducted using the paired or unpaired Student's t test as appropriate or the ANOVA when more than two groups were compared.
Results
Immunofluorescence and immunoelectron microscopy detection of ACh receptors in IBDU.
Exposure to the anti-mAChR mAb M35 yielded a specific reaction product on normal rat cholangiocytes, as shown by both indirect immunofluorescence ( Fig. 1) , light, and immunoelectron microscopy ( Fig. 2 ).
Under the light microscope, M35 immunoreactivity stained the membrane of the cholangiocytes. The immunofluorescence was distributed at the periphery of the cytoplasm with a preferential localization in the basolateral area of cholangiocytes ( Fig. 1 ) as shown by a basolateral immunofluorescence total value higher than the apical value (8.16Ϯ1.2 versus 3.63Ϯ1.02 fluorescence units; P Ͻ 0.01). No differences were found between ducts of diameter Ͻ 50 m and ducts of diameter Ͼ 50 m (basolateral fluorescence 8.5Ϯ1.2 and 7.99Ϯ1.1 respectively, and apical fluorescence 3.1Ϯ1.1 and 2.61Ϯ0.2 fluorescence units). In sample preincubated with 40 nM of 4-DAMP, for 20 min at 37ЊC, and exposed to the anti-mAChR M35 antibody, no staining was evident at the level of cholangiocytes. At the ultrastructural level there was evidence of deposition of a dense reaction product along the basolateral membranes, with a preferential localization at the level of invaginations of the cell membrane (Fig. 2 a) . The morphological features of these invaginations were often reminiscent of coated pits, suggesting receptor-mediated endocytosis (Fig. 2 a) .
When different sections were exposed to the M2 muscarinic ACh receptor monoclonal antibody, a specific staining was evident in endothelial cells of the vascular wall near to bile ducts. In contrast, no staining appeared at the level of plasmamembrane of biliary epithelial cells.
Effect versus 0.184Ϯ0.017 pHU/min, H ϩ flux ϭ 12.24Ϯ1.095 versus 11.32Ϯ1.25 mM/min). These experiments indicate that ACh has no effect on the basal activity of the Cl
To evaluate whether ACh could influence the secretin stimulation of the Cl Ϫ /HCO 3 Ϫ exchanger activity, two sequential Cl Ϫ removal/readmission maneuvers were performed, the second during exposure to ACh (10 M) ϩ secretin (50 nM) (Fig. 3 , Table I ). Findings were compared with experiments where secretin alone was administered in correspondence with the second Cl Ϫ removal/readmission maneuver (Fig. 3 , Table  I ). Secretin alone (second maneuver) significantly (P Ͻ 0.02) enhanced the maximal rate of alkalinization after Cl Ϫ removal as well as the maximal rate of pH i recovery after Cl Ϫ readmission compared with correspondent parameters measured in the absence of this hormone. This confirms (4, 19) carinic receptor antagonist with a high affinity for M3 subtype receptor (42) (43) (44) (45) (46) . Two sequential Cl Ϫ removal/readmission maneuvers were then performed, the second during exposure to 50-nM secretin or 50-nM secretin plus 10-M ACh. Findings were compared with similar paired experiments performed in the absence of 4-DAMP (Fig. 4, Table II ).
4-DAMP showed no effect on the secretin stimulation of the Cl Ϫ /HCO 3 Ϫ exchanger activity. The maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin (second maneuver) were similar both in the absence and presence of 4-DAMP (Fig. 4) .
In contrast, in the presence of 4-DAMP, ACh failed to increase the secretin stimulatory effect on the activity of Cl Ϫ / HCO 3 Ϫ exchanger. In fact, the maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin plus ACh (second maneuver) were significantly (P Ͻ 0.03) lower in the presence than in the absence of 4-DAMP. From the parameters measured after Cl Ϫ removal, the Cl /HCO 3 Ϫ exchanger activity was evaluated by measuring the maximal rate of alkalinization after Cl Ϫ removal (equimolar substitution with gluconate) and the maximal rate of pH i recovery after Cl Ϫ readmission. Two sequential Cl Ϫ removal/readmission maneuvers were performed, the second during superfusion with 10-M ACh (top, n ϭ 25), 50-nM secretin (middle, n ϭ 19) or ACh plus secretin (bottom, n ϭ 29). ACh alone showed no effect on the maximal rate of alkalinization after Cl Ϫ removal nor on the maximal rate of pH i recovery after Cl Ϫ readmission in comparison with correspondent control parameters (first Cl Ϫ removal/readmission maneuver). Secretin alone increased both the rate of intracellular alkalinization after Cl Ϫ removal and the rate of pH i recovery after Cl Ϫ readmission in comparison with correspondent control parameters (first Cl Ϫ removal/readmission maneuver). Exposure to ACh plus secretin (bottom, second maneuver), induced an additional increase in both the rate of intracellular alkalinization after Cl Ϫ removal and the rate of pH i recovery after Cl Ϫ readmission, compared with correspondent parameters measured during exposure to secretin alone (middle, second Cl Ϫ removal/readmission maneuver). Two sequential Cl Ϫ removal/readmission maneuvers were performed, the second during exposure to secretin (50 nM) or ACh (10 M) plus secretin in controls or in IBDU pretreated and perfused with 4-DAMP, a muscarinic acetylcholine receptor antagonist with high affinity for M3 receptors. Data were compared with experiments performed in the absence of 4-DAMP. *P Ͻ 0.02 versus control values.
‡ P Ͻ 0.03 versus ACh plus secretin.
§ P Ͻ 0.05 versus secretin alone. Data are meanϮSEM.
Findings were compared with similar paired experiments performed in the absence of BAPTA/AM (Table III) . BAPTA/AM showed no effect on the secretin stimulation of the Cl Ϫ /HCO 3 Ϫ exchanger. In fact, the maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin (second maneuver) were similar either in the absence or presence of BAPTA/AM. From the parameters measured after Cl Ϫ removal, the Cl Ϫ /HCO 3 Ϫ exchanger activity appears to be stimulated 64% by secretin in the absence of BAPTA/AM and 65% in the presence of BAPTA/AM. In contrast, chelation of intracellular Ca 2ϩ with BAPTA/AM completely inhibited the effect of ACh on the secretin stimulation of Cl Ϫ / HCO 3 Ϫ exchanger activity. In fact, the maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin plus ACh (second maneuver) were significantly lower (P Ͻ 0.03) in the presence than in the absence of BAPTA/AM. The stimulation of the Cl Ϫ /HCO 3 Ϫ exchanger activity by secretin plus ACh decreased from 109% in control conditions to 62% in the presence of BAPTA/AM. Ϫ exchanger activity, by using the PKC inhibitor staurosporine. IBDU exposed to 0.1-M staurosporine were submitted to two sequential Cl Ϫ removal/ readmission maneuvers, the second during administration of secretin plus ACh (Table IV) . Findings were compared with similar paired experiments performed in the absence of staurosporine. The maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin plus ACh were similar both in the absence and presence of staurosporine. From the parameters measured after Cl Ϫ removal, the Cl Ϫ /HCO 3 Ϫ exchanger activity appears to be stimulated 120% by secretin plus ACh in the absence of staurosporine and 123% in the presence of staurosporine. Staurosporine alone (Table IV) ization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin were similar both in the absence and presence of FK-506. From the parameters measured after Cl Ϫ removal, the Cl Ϫ / HCO 3 Ϫ exchanger activity appears to be similarly stimulated by secretin both in the absence (ϩ63%) and presence (ϩ70%) of FK-506, indicating that the calcineurin inhibitor has no impact on the stimulatory effect of secretin on the anion exchanger.
Effect of staurosporine on ACh plus secretin-induced stimulation of Cl
In contrast, in IBDU treated with FK-506, ACh failed to increase the response rate to secretin. In fact, the activity of the Cl Ϫ /HCO 3 Ϫ exchanger measured during exposure to secretin plus ACh (second manuever) was significantly lower (P Ͻ 0.03) in IBDU treated with FK-506 in comparison to untreated controls (Fig. 5, Table V ). In IBDU incubated with FK-506, the activity of the Cl Ϫ /HCO 3 Ϫ exchanger measured during exposure to secretin plus ACh (second maneuver) was significantly (P Ͻ 0.02) higher in comparison with the basal values (first control maneuver) but similar to that measured in the presence of secretin alone (Fig. 5, Table V ). ACh plus secretin stimulated by 104% the Cl Ϫ /HCO 3 Ϫ exchanger activity in control IBDU, but only 53% in FK-506 treated IBDU. Studies in isolated cholangiocytes. Virtually pure preparations of cholangiocytes were isolated from normal rat liver, a purity commonly achieved by immunoaffinity separation (27) (28) (29) (30) (31) . Hepatocytes and mesenchymal cells were not present. Viability, assessed by trypan blue exclusion, was always Ͼ 99%.
Molecular analysis by RT-PCR shows that cholangiocytes from normal rat liver express the transcript for CK-19, a specific marker of cholangiocytes (3, 34) . As shown in Fig. 6 , the transcript for the M3 ACh receptor (375 bp) was present in brain (positive controls) but not in yeast transfer RNA (negative control). By RT-PCR, a 375-bp, 100% homologous to the published sequence for the M3 ACh receptor (35) , was detected in normal cholangiocytes.
On the contrary, we did not detect by RT-PCR the presence of the transcript for the M1 muscarinic ACh receptor in pure preparations of cholangiocytes from normal rat liver (three cell preparations).
cAMP intracellular levels in isolated cholangiocytes. Fig. 7 shows intracellular cAMP levels in isolated cholangiocytes incubated with agonists and inhibitors under experimental conditions similar to those used for the pH i measurement in IBDU. Secretin alone induced a twofold increase in cAMP basal levels (38.0Ϯ1.08 versus 18.13Ϯ1.369 fmol/10 5 cells; P Ͻ 0.01), while ACh alone (17.22Ϯ0.653 fmol/10 5 cells) showed no effect. However, when isolated cholangiocytes were exposed to secretin plus ACh, the cAMP intracellular levels (54.17Ϯ2.017 fmol/10 5 cells), were significantly higher (P Ͻ 0.01) than those measured in the presence of secretin alone. (Fig. 7) . In addition, se- Ϫ exchanger activity. IBDU, preincubated (30-45 min) with 100-nM FK-506, were submitted to two sequential Cl Ϫ removal/readmission maneuvers, the second during administration of secretin (top right) or secretin plus ACh (bottom right). The findings were compared with similar paired experiments performed in the absence of FK-506 (SECRETIN, top left; secretin plus ACh, bottom left). The maximal rate of alkalinization after Cl Ϫ removal and the maximal rate of pH i recovery after Cl Ϫ readmission measured during exposure to secretin were similar both in the absence and presence of FK-506. In contrast, in IBDU treated with FK-506, ACh failed to increase the response rate to secretin. major subtypes (M1-M4) with different tissue distribution, pharmacology, and functions (42) (43) (44) (45) (46) . At least five distinct but related muscarinic genes (m1-m5) have been demonstrated recently by molecular cloning studies, but the expressed product of the m5 receptor gene does not yet have an equivalent functional pharmacological profile nor a defined tissue localization (42) (43) (44) (45) (46) . From a functional point of view, M1, M3, and M5 are preferentially coupled to hydrolysis of phosphoinositide, while M2 and M4 to the inhibition of the adenylyl cyclase activity (42) (43) (44) (45) (46) . In this study we used a monoclonal antibody to detect the occurrence of muscarin receptors in IBDU by immunofluorescence and immunoelectron microscopy. The antibody used (M35) recognizes both M2 and M3 subtype receptors (21-23), but the immunofluorescence study performed by using another antibody specific for M2 subtypes yielded negative findings, suggesting that those findings obtained with M35 are related to the distribution of M3 receptor subtypes. These appeared extensively represented in cholangiocytes without differences relative to the size of the ducts, but with a significantly higher staining of the basolateral compared to the apical membranes. In addition, at the ultrastructural level there was a preferential localization at the level of invaginations of the cell membrane with subcellular features reminiscent of coated pits, suggesting a process of receptor-mediated endocytosis. The occurrence of M3 receptor subtypes has also been confirmed by the RT-PCR analysis performed in pure preparations of rat cholangiocytes. On the contrary, M2 subtype receptors were not found by indirect immunofluorescence in IBDU and, the transcript for M1 subtype receptor, was not detected by RT- (Fig. 7) . In contrast, in isolated cholangiocytes preincubated with FK-506 or cyclosporin A, ACh plus secretin induced no further increase in cAMP levels (32.60Ϯ1.08 and 34.66Ϯ1.91 fmol/10 5 cells, respectively) in comparison with secretin alone. These experiments indicate that ACh potentiation of secretin-stimulated cAMP accumulation is dependent on calcineurin activity in that it is blocked by two distinct inhibitors of calcineurin.
Discussion
The main findings emerging from this study are that: (a) M3 ACh receptors are present in IBDU of different sizes, while M1 and M2 subtypes are absent; (b) ACh has no effect on the basal activity of the Cl Ϫ /HCO 3 Ϫ exchanger, but it significantly potentiates the stimulatory effect of secretin on this anion exchanger; (c) the effect of ACh is abolished by 4-DAMP, a muscarinic receptor antagonist with high affinity for M3 subtype; (d) the ACh-induced potentiation of the secretin stimulatory effect on the Cl Ϫ /HCO 3 Ϫ exchanger appears to be mediated by intracellular Ca 2ϩ as it is sensitive to the intracellular Ca 2ϩ chelator BAPTA/AM, but is not mediated by PKC as it is staurosporine insensitive; and (e) ACh acts by potentiating the secretin induced cAMP intracellular levels, through a calcineurin mediated regulation of adenylyl cyclase activity.
ACh muscarinic receptors are presently classified into four PCR, in virtually pure (27, 30, 31, 39) preparations of cholangiocytes. This latter finding is in contrast with recent observations (37) showing the presence of M1 subtype ACh receptor mRNA in impure (75% by ␥-GT staining) preparations of rat cholangiocytes. The discrepancies between the molecular results, performed with the same RT-PCR methodology, presumably depend on the degree of purity of cholangiocyte preparation.
In peripheral tissues, M3 receptor subtypes have been detected in smooth muscles, exocrine glands, urinary bladder, small intestine and gastric antral cells (42) (43) (44) (45) . Stimulation of muscarinic receptors, either by ACh from parasympathetic nerves or muscarinic agonists, induced secretion in exocrine glands including tear glands, sweat glands, salivary glands, and pancreas (16, 17, 42, 44) . In all these tissues, Northern blot analysis and receptor specific antibody immunoprecipitation studies indicate the presence of M1 and M3 receptors which are frequently coexpressed and are both coupled to hydrolysis of phosphoinositide and Ca 2ϩ increase (42) (43) (44) . Functional studies. Bicarbonate secretion in the lumen of intrahepatic ducts is one of the major functions of cholangiocytes (1) (2) (3) (4) . This is driven by the Cl Ϫ /HCO 3 Ϫ exchanger, an anion exchanger that has been identified by immunohistochemistry in the apical pole of human cholangiocytes (47) , and functionally characterized in the rat (4) and human isolated cholangiocytes (48) . The Cl Ϫ /HCO 3 Ϫ exchanger, thought to be the major mechanism of bicarbonate excretion in a number of bicarbonate secretory epithelia, is stimulated by different hormones targeting cholangiocytes, including secretin (4, 19, 29, 33) , bombesin (5), and vasoactive intestinal peptide (6), thus providing the basis for hormonal induced bicarbonate rich ductal choleresis. In IBDU, forskolin, secretin, bombesin, and vasoactive intestinal peptide, by enhancing the activity of the anion exchanger, induce an expansion of lumenal space together with an alkalinization of lumenal pH, as direct evidence of stimulated bicarbonate-rich ductal fluid secretion (4) (5) (6) 19) . We explored the effect of ACh on both basal and secretin stimulated Cl Ϫ / HCO 3 Ϫ exchanger activity by using a method (pH i changes induced by acute Cl Ϫ removal/readmission) widely used to assess the activity of this anion exchanger (2, . cAMP intracellular levels in isolated cholangiocytes incubated with agonists and inhibitors under the same experimental conditions as those for the pH i measurement in IBDU. Secretin alone (50 nM) induced a twofold increase (P Ͻ 0.01) in cAMP basal levels, while ACh (10 M) alone showed no effect. However, when isolated cholangiocytes were exposed to secretin plus ACh, the cAMP intracellular levels were significantly higher (P Ͻ 0.01) than those measured in the presence of secretin alone. Preincubation (45 min) with 100-nM FK-506 or 100-nM cyclosporin A does not affect basal-nor secretin-induced cAMP levels. However, in isolated cholangiocytes preincubated with FK-506 or cyclosporin A, ACh plus secretin induced no further increase in cAMP levels in comparison with secretin alone. Data are meanϮSEM from 3-15 experiments. Statistical comparison was performed using the ANOVA. *P Ͻ 0.01 versus basal; **P Ͻ 0.01 versus secretin or basal; @, P Ͻ 0.01 versus FK-506; #, P Ͻ 0.01 versus FK-506; $, P Ͻ 0.01 versus cyclosporin A; &, P Ͻ 0.01 versus cyclosporin A. 4-6, 19, 25, 26, 29) . The rationale for studying the coordinated effect of secretin and ACh derives from the fact that secretin targets the intrahepatic biliary epithelium in a period (digestive phase) of parasympathetic predominance (9, 10 3 Ϫ exchanger activity induced by ACh. For both BAPTA/AM and staurosporine, an aspecific toxic effect could be excluded by the fact that these substances did not influence the intracellular pH i , the basal activity of the Cl Ϫ /HCO 3 Ϫ exchanger, nor the rate of response to secretin alone. To further elucidate the ACh mechanism of action, we measured cAMP intracellular levels in isolated cholangiocytes. While ACh alone failed to influence the intracellular levels of cAMP, when administered together with secretin, ACh doubled the secretin-induced cAMP intracellular accumulation indicating a sensitization of adenylyl cyclase to secretin. An effect of ACh on cAMP breakdown may be excluded since measurement of cAMP intracellular levels have been performed in the presence of IBMX concentration that should fully inhibit soluble phosphodiesterases. An increase in adenylyl cyclase activity has been reported in different cell types after stimulation of M1, M3, and M5 receptor subtypes and this effect is thought to occur by activation, via IP3/Ca 2ϩ , of Ca 2ϩ -sensitive adenylyl cyclase isoforms (42, (49) (50) (51) (52) (53) . On the contrary, stimulation of M2/M4 subtype receptors generally has been coupled with an inhibition of a previously stimulated adenylyl cyclase, via pertussis toxin-sensitive G proteins (42) (43) (44) (45) (46) 49) . However, M2 receptor subtypes have been not detected by immunofluorescence in IBDU and M4 subtypes have only been detected so far in the rat striatum and rabbit lung, but not in the pancreas, intestine, or salivary glands (42) (43) (44) (45) (46) 49) .
Thus our findings indicate that ACh elicits a sensitization of the adenylyl cyclase complex to cAMP agonists, such as secretin, by a mechanism of interaction at the second messenger level. This mechanism is responsible of the ACh-induced potentiation of the secretin stimulatory effect on the Cl Ϫ /HCO 3 Ϫ exchanger. In secretory epithelia, including colonic cell lines (53) , intestinal epithelia (54), pancreatic acini (51, 55) , salivary glands (16) and gastric chief cells (56) , cross-talk between the Ca 2ϩ and cAMP signaling pathways has been shown to be of relevance in the regulation of secretory processes. It is known that Ca 2ϩ may regulate cAMP production, but the mechanisms of the cross-talk between the two signaling pathways have only recently begun to be investigated at a molecular level. PKC, G proteins, Ca 2ϩ -calmodulin complex, and calcineurin have been differently involved as regulatory components of the cascade (53) (54) (55) (56) (57) (58) . The cross-talk between Ca 2ϩ and cAMP signaling pathways may be responsible for either potentiating or terminating agonist-stimulated second messenger level, depending on the cell system under investigation. In our cell system, the cross-talk between signaling pathways seems to be mediated by calcineurin, since two distinct calcineurin inhibitors (cyclosporin A and FK-506), without influencing other cell function parameters, blocked the stimulatory effect of ACh on secretin-induced cAMP levels and Cl Ϫ /HCO 3 Ϫ exchanger activity. Moreover, the rabbit anti-protein phosphatase 2B␣ polyclonal antibody (i.e., calcineurin) yielded a specific reaction product on normal IBDU, as shown by indirect immunofluorescence (personal observation). The inhibitory effect of FK-506 and cyclosporin A on calcineurin activity has been widely documented in many different cell types where it depends on binding to the immunophillins FK-binding protein 12 (FK506) and cyclophillin (cyclosporine) (40, 41) . Calcineurin is a Ca 2ϩ -calmodulin-dependent serine/threonine phosphatase 2B, which plays a role in signal transduction in different secretory epithelia other than in nervous tissues (40, 41) . Calcineurin activation, in fact, induces enzyme secretion in pancreatic acini, zymogen granule fusion in parotid glands, and pepsinogen secretion in gastric chief cells (55, 56, 59 ). In a number of different cell types (52, 55, 56, 59) , Ca 2ϩ agonists have been shown to regulate adenylyl cyclase activity by a Ca 2ϩ -calmodulin-dependent activation of calcineurin that in turn selectively acts on certain adenylyl cyclase isoforms. At least ten different isoforms of adenylyl cyclases have been described to date (60) (61) (62) (63) (64) (65) . Other than having distinct tissue distribution profiles, they largely differ with respect to regulation by G proteins, Ca 2ϩ calmodulin, calcineurin and PKC (60) (61) (62) (63) (64) (65) . Isoforms I, III, and VIII have been reported to be stimulated by the Ca 2ϩ -calmodulin complex and/or calcineurin (63) (64) (65) . In dispersed gastric chief cells, Ca 2ϩ mobilizing agents, including cholinergic agonists, lead to a potentiation of cholera toxinand forskolin-induced pepsinogen secretion by an augmentation of cAMP cellular levels and, recently, calcineurin has been proposed as the mediator of the cross-talk between the Ca 2ϩ and adenylyl cyclase signaling pathways (56) . In bovine adrenal glomerulosa cells (52) , angiotensin II induced enhancement of ACTH-stimulated cAMP formation, an effect partially mediated by PKC (staurosporine sensitivity) and completely by calcineurin (inhibition by FK-506 and cyclosporine). In this study, a regulation of G proteins and/or adenylyl cyclase activities by phosphorylation/dephosphorylation steps (PKC/calcineurin) has been suggested as the underlying mechanism of the crosstalk between Ca 2ϩ and cAMP. On the contrary, in other cell systems, including mouse pituitary tumor (AT10) cells (57) , calcineurin exerts a feedback inhibition of agonist-evoked cAMP formation, an effect also documented in purified bovine brain adenynyl cyclase (66) . Expression of different isoforms of adenylyl cyclase or G proteins could explain the divergent effects of Ca 2ϩ documented in different cell types. Since ATP, like ACh, elicits cytosolic Ca 2ϩ signaling in IBDU without a direct effect on fluid secretion (18), the interaction of ATP with secretin or other cAMP agonists in modulating ductal fluid secretion should be investigated in light of the present findings.
In conclusion, this study provides morphological and functional evidence that ACh plays a role in the regulation of bicarbonate secretion from biliary ducts. This regulation probably takes place during the digestive phase when the parasympathetic system predominates and secretin targets the biliary epithelium. In this phase the bicarbonate requirement in the intestine is maximal. By acting on M3 receptor subtypes, ACh induces a Ca 2ϩ -calcineurin mediated potentiation of the secretin-induced adenylyl cyclase activity. The doubled cAMP intracellular levels generate an almost maximal stimulation of Cl Ϫ /HCO 3 Ϫ exchanges and bicarbonate excretion in the ductal lumen. The modulating action of Ca 2ϩ on adenylyl cyclase could serve as a means of amplifying the secretory response and prevent the impairment of the overall secretory process.
